Clinical Trial: Transition From Buphenyl to RAVICTI for the Therapy of Byler Disease

Study Status: No longer available
Recruit Status: No longer available
Study Type: Expanded Access

Official Title: Transition From Buphenyl to RAVICTI for the Therapy of Byler Disease

Brief Summary: This is a single patient compassionate use protocol to determine whether RAVICTI will improve bile flow in a subject who previously tolerated therapy with Buphenyl.

Detailed Summary:
Sponsor: University of Pittsburgh

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: University of Pittsburgh

Dates:
Date Received: September 20, 2013
Date Started:
Date Completion:
Last Updated: September 20, 2013
Last Verified: September 2013